Literature DB >> 12401611

Changes of propofol concentration in cerebrospinal fluid during continuous infusion.

Andrzej L Dawidowicz1, Rafal Kalityński, Andrzej Nestorowicz, Anna Fijalkowska.   

Abstract

UNLABELLED: We studied the changes in the propofol concentration in the cerebrospinal fluid (CSF) in 14 patients, undergoing elective intracranial procedures, who were anesthetized with propofol administered by target-controlled infusion. During anesthesia, fentanyl and cisatracurium were administered as required. After intubation of the trachea, the lungs of the patients were ventilated to normocapnia with an oxygen-air mixture (FIO(2) = 0.33). Arterial blood and CSF samples (from an intraventricular drain) were collected between 90-180 min after the induction of anesthesia. Blood propofol concentrations were stable, between 5.0 +/- 1.89 and 4.5 +/- 1.7 microg/mL (mean +/- SD). There was a significant decrease in the CSF propofol concentration, from 52.2 +/- 35.01 ng/mL at 90 min to 28.6 +/- 21.9 ng/mL at 150 min (P < 0.05). The CSF propofol concentration at 180 min (21.4 +/- 14.0 ng/mL) was not significantly different from the concentration at 150 min. Some possible reasons for this decrease after commencing continuous intraventricular drainage are discussed. IMPLICATIONS: Propofol concentrations in the cerebrospinal fluid in neurosurgical patients Propofol concentration in cerebrospinal fluid of investigated patients decreased significantly after starting intraventricular drainage, despite relatively steady blood propofol concentrations. These results supplement the limited information about propofol pharmacokinetics in the human central nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401611     DOI: 10.1097/00000539-200211000-00033

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Use of propofol to control refractory involuntary movements.

Authors:  David V Lardizabal; Vivek Sabharwal; Ali Jahan; Samay Jain; Christopher Snyder; Marc J Popovich; Michael DeGeorgia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  HCN1 channels as targets for anesthetic and nonanesthetic propofol analogs in the amelioration of mechanical and thermal hyperalgesia in a mouse model of neuropathic pain.

Authors:  Gareth R Tibbs; Thomas J Rowley; R Lea Sanford; Karl F Herold; Alex Proekt; Hugh C Hemmings; Olaf S Andersen; Peter A Goldstein; Pamela D Flood
Journal:  J Pharmacol Exp Ther       Date:  2013-04-02       Impact factor: 4.030

3.  Free and bound propofol concentrations in human cerebrospinal fluid.

Authors:  Andrzej L Dawidowicz; Rafal Kalitynski; Anna Fijalkowska
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.